[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 1125489, "exercisedValue": 0, "unexercisedValue": 657452}, {"maxAge": 1, "name": "Ms. Daniella  Beckman CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 717616, "exercisedValue": 0, "unexercisedValue": 337565}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 674222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 882167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Alan  Ashworth FRS, Ph.D.", "age": 63, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 57, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth Pingpank Hickin", "title": "VP of IR & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.01, "open": 7.9, "dayLow": 7.37, "dayHigh": 8.13, "regularMarketPreviousClose": 8.01, "regularMarketOpen": 7.9, "regularMarketDayLow": 7.37, "regularMarketDayHigh": 8.13, "payoutRatio": 0.0, "beta": 1.754, "forwardPE": -5.5422535, "volume": 2327275, "regularMarketVolume": 2327275, "averageVolume": 2735737, "averageVolume10days": 3070860, "averageDailyVolume10Day": 3070860, "bid": 7.81, "ask": 7.88, "bidSize": 21, "askSize": 1, "marketCap": 1059254784, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 9.7, "allTimeHigh": 18.84, "allTimeLow": 1.03, "priceToSalesTrailing12Months": 15.928404, "fiftyDayAverage": 7.7118, "twoHundredDayAverage": 4.584925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 941206784, "profitMargins": -1.51148, "floatShares": 74014585, "sharesOutstanding": 134593998, "sharesShort": 36347898, "sharesShortPriorMonth": 26798166, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.32669997, "heldPercentInsiders": 0.049450003, "heldPercentInstitutions": 0.92561996, "shortRatio": 13.11, "shortPercentOfFloat": 0.39200002, "impliedSharesOutstanding": 134593998, "bookValue": 1.434, "priceToBook": 5.488145, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -100515000, "trailingEps": -0.91, "forwardEps": -1.42, "enterpriseToRevenue": 14.153, "enterpriseToEbitda": -8.722, "52WeekChange": 1.3284023, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 7.87, "targetHighPrice": 15.0, "targetLowPrice": 11.0, "targetMeanPrice": 12.83333, "targetMedianPrice": 12.5, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 152811008, "totalCashPerShare": 1.135, "ebitda": -107913000, "totalDebt": 34763000, "quickRatio": 8.285, "currentRatio": 8.88, "totalRevenue": 66501000, "debtToEquity": 21.723, "revenuePerShare": 0.602, "returnOnAssets": -0.24517, "returnOnEquity": -0.51652, "grossProfits": -67500000, "freeCashflow": -62384376, "operatingCashflow": -145815008, "revenueGrowth": 3.636, "grossMargins": -1.01502, "ebitdaMargins": -1.6227299, "operatingMargins": 0.26150998, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.74782, "regularMarketPrice": 7.87, "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "marketState": "CLOSED", "fiftyTwoWeekRange": "1.03 - 9.7", "fiftyTwoWeekHighChange": -1.8299999, "fiftyTwoWeekHighChangePercent": -0.18865979, "fiftyTwoWeekChangePercent": 132.84023, "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.91, "epsForward": -1.42, "epsCurrentYear": -0.88, "priceEpsCurrentYear": -8.943182, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 0.15819979, "fiftyDayAverageChangePercent": 0.020513989, "twoHundredDayAverageChange": 3.2850747, "twoHundredDayAverageChangePercent": 0.71649474, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": -1.5247762, "postMarketPrice": 7.75, "postMarketChange": -0.119999886, "regularMarketChange": -0.14, "regularMarketDayRange": "7.37 - 8.13", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2735737, "fiftyTwoWeekLowChange": 6.84, "fiftyTwoWeekLowChangePercent": 6.640777, "corporateActions": [], "postMarketTime": 1762560280, "regularMarketTime": 1762549201, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]